Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00825734 | Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 83 | SCRI Development Innovations, LLCOTHER | 1 | Dec 22, 2014 | clinicaltrials |
| NCT00968656 | Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1(FISO PET/CT) | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01238029 | Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer(CELAVIE) | terminated | Phase 1 | 12 | Sponsor GmbHOTHER | 1 | Nov 21, 2014 | clinicaltrials |
| NCT01259505 | Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer | completed | Phase 1 | 10 | Tokyo Medical UniversityOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01238952 | Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer | completed | Phase 1 | 4 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT01077453 | Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer | completed | Phase 1 | 112 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01672684 | Phase I: At-Home Support for Rural Women Using Group Video Calling | completed | Phase 1 | 34 | Stanford UniversityOTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01993576 | ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.(EC2075) | completed | Phase 1 / Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00924352 | Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 56 | Accelerated Community Oncology Research NetworkOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT00393497 | A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment | completed | Phase 1 | 11 | Indiana UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00107211 | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast | completed | Phase 1 | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00516243 | Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Sep 12, 2014 | clinicaltrials |
| NCT00003107 | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors | completed | Phase 1 | — | Indiana UniversityOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT01333137 | A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin | terminated | Phase 1 | 11 | Piramal Enterprises LimitedINDUSTRY | 1 | Sep 4, 2014 | clinicaltrials |
| NCT01159405 | The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer | unknown | Phase 1 | 9 | SeeCure LLCINDUSTRY | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00405678 | Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. | completed | Phase 1 / Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT01003158 | Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. | completed | Phase 1 | 17 | AstraZenecaINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01423123 | Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer | completed | Phase 1 | 21 | NSABP Foundation IncNETWORK | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00544804 | Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 1 | 41 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00004207 | Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT01256567 | A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer | completed | Phase 1 | 7 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00258349 | Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 1 / Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2014 | clinicaltrials |
| NCT01741597 | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT00217399 | Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00470847 | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer | completed | Phase 1 | 35 | Nancy Lin, MDOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01335152 | Online Stress Management and Coping Skills Training for Women With Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Talaria, IncINDUSTRY | 1 | May 7, 2014 | clinicaltrials |
| NCT00645333 | Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 4, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01539876 | Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel(TNFactor) | withdrawn | Phase 1 | 0 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00724386 | Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer | completed | Phase 1 | 26 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00074139 | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer | withdrawn | Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT01131364 | Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients | terminated | Phase 1 / Phase 2 | 29 | Philogen S.p.A.INDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00068614 | HER-2 Protein Vaccine in Treating Women With Breast Cancer | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00513058 | Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 33 | UNICANCEROTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00002627 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | unknown | Phase 1 / Phase 2 | 30 | St. Louis UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002628 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 50 | St. Louis UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002780 | Biological Therapy in Treating Women With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 60 | St. Luke's Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00022425 | Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy | unknown | Phase 1 | — | The Cleveland ClinicOTHER | 1 | Dec 18, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Dec 23, 2014source: clinicaltrials